Mt. Sinai

New York, New York 10032

5 studies enrolling now · 27 studies all time

What they study most

Abdominal Aortic Aneurysms (AAA), Acute Respiratory Distress Syndrome, Adolescent Behavior, Advanced/Metastatic Solid Tumors, Asthma, Bariatric - Sleeve Gastrectomy Staple Line Reinforcement, Cardiomyopathy, Dilated, Carotid Artery Diseases, Carotid Artery Stenosis, Carotid Stenosis, Child Behavior, Colorectal Cancer

Studies at this site

• A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — Recruiting now
• Vivistim Registry for Paired VNS Therapy (GRASP) — Recruiting now
• CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
• Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA — Recruiting now
• PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life — Recruiting now
• The Canopy Cancer Collective Clinical Registry Protocol — Starting soon
• Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies — Completed
• Post-Market Clinical Follow-Up of STRATAFIX™ Spiral PDS™ PLUS — Completed
• Starzl Network Patient Reported Outcomes — Completed
• High-Risk Skin Cancers With Atezolizumab Plus NT-I7 — Stopped early
• A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma — Running, not enrolling
• Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction — Running, not enrolling
• Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs — Running, not enrolling
• Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System — Running, not enrolling
• KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment — Status unconfirmed
• Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN — Stopped early
• Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief — Completed
• Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses — Completed
• Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases — Completed
• Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP) — Completed
• Phase III Confirmatory Study in Erythropoietic Protoporphyria — Completed
• The Chimerix CMX001 Registry — Stopped early
• International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol — Completed
• Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula — Completed
• STIP: Statin Trial for Influenza Patients — Stopped early
• Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases — Withdrawn before enrolling
• HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection — Stopped early